ORTHOCELL LIMITED - Announcements

0.41%

$1.24

Market Cap $307.2M

Technology Scientific & Technical Instruments

Orthocell Limited is an Australia-based regenerative medicine company. The Company is... Orthocell Limited is an Australia-based regenerative medicine company. The Company is focused on regenerating mobility for patients by developing products for the repair of a variety of bone and soft tissue injuries. Its portfolio of products includes Striate+, Remplir, and OrthoACI. Striate+ is a sterile, resorbable collagen membrane used for guided bone and tissue regeneration in dental applications. Remplir is a collagen scaffold used in peripheral nerve repair. OrthoACI or autologous chondrocyte implantation is used for the treatment of articular cartilage defects in the knee and ankle. OrthoACI uses the patient’s own healthy cartilage cells called chondrocytes to assist the regeneration of damaged cartilage. The Company is engaged in the development of its tendon cell therapy in the United States. Its autologous tendon therapy is an advanced injectable cellular therapy for the treatment of chronic tendon injuries.More

Race Oncology (ASX: RAC) is an ASX-listed clinical stage biopharmaceutical company with a dedicated mission to be at the heart of cancer care. LATEST: Race Oncology Accelerates Game-Changing Cancer Drug.

Announcements

Filter Results

All Price Sensitive Only

OCC	Orthocell Appoints Non-Executive Director Dr Ravi Thadhani		08/03/23	231.18KB	Share
OCC	Orthocell appoints Company Secretary Mr Peter Webse		01/03/23	132.61KB	Share
OCC	Half Yearly Report and Accounts	PRICE SENSITIVE	28/02/23	4.16MB	Share
OCC	Investor Presentation		02/02/23	12.22MB	Share
OCC	Appendix 4C - Quarterly	PRICE SENSITIVE	30/01/23	456.15KB	Share
OCC	Change of Director's Interest Notice PA		23/11/22	196.01KB	Share
OCC	Change of Director's Interest Notice LL		23/11/22	197.93KB	Share
OCC	Notification of cessation of securities - OCC		23/11/22	22.56KB	Share
OCC	Notification of cessation of securities - OCC		23/11/22	22.49KB	Share
OCC	Change of Director's Interest Notice LL Revised		11/11/22	320.85KB	Share
OCC	Change of Director's Interest Notice LL		09/11/22	198.1KB	Share
OCC	Remplir Gains Australian Reimbursement	PRICE SENSITIVE	01/11/22	299.94KB	Share
OCC	Appendix 4C - Quarterly	PRICE SENSITIVE	31/10/22	442.67KB	Share
OCC	Results of Meeting		28/10/22	140.26KB	Share
OCC	Investor Presentation		26/10/22	5.72MB	Share
OCC	OrthoATI Rotator Cuff Study Success With Cross-Over Patients	PRICE SENSITIVE	29/09/22	273.87KB	Share
OCC	Letter to Shareholders - Annual General Meeting		28/09/22	727.9KB	Share
OCC	Notice of Annual General Meeting/Proxy Form		28/09/22	851.1KB	Share
OCC	First orders for Striate and Remplir	PRICE SENSITIVE	27/09/22	185.26KB	Share
OCC	Appointment of Exclusive Australian Distributor for Remplir	PRICE SENSITIVE	07/09/22	328.63KB	Share
OCC	Trading Halt	PRICE SENSITIVE	06/09/22	564.01KB	Share
OCC	Annual General Meeting		05/09/22	151.23KB	Share
OCC	Appendix 4G		31/08/22	304.06KB	Share
OCC	Final Report and Annual Report to Shareholders	PRICE SENSITIVE	31/08/22	5.09MB	Share
OCC	Notice under Section 708(A) of the Corporations Act		17/08/22	146.15KB	Share
OCC	Notification of cessation of securities - OCC		17/08/22	22.54KB	Share
OCC	Application for quotation of securities - OCC		17/08/22	26.67KB	Share
OCC	Appendix 4C - Quarterly	PRICE SENSITIVE	29/07/22	541.28KB	Share
OCC	Updated Investor Presentation		27/07/22	6.08MB	Share
OCC	Striate Global License and Distribution Agreement Update	PRICE SENSITIVE	21/07/22	211.95KB	Share
OCC	Option Terms and Conditions		15/07/22	200.03KB	Share
OCC	Notification regarding unquoted securities - OCC		14/07/22	28.25KB	Share
OCC	Notification regarding unquoted securities - OCC		14/07/22	24.98KB	Share
OCC	Notification of cessation of securities - OCC		29/06/22	22.48KB	Share
OCC	OCC Signs Striate Global License And Manufacturing Agreement	PRICE SENSITIVE	27/06/22	205.1KB	Share
OCC	Trading Halt	PRICE SENSITIVE	24/06/22	553.19KB	Share
OCC	Notification of cessation of securities - OCC		15/06/22	22.48KB	Share
OCC	Final Data Readout for Orthocells Nerve Reconstruction Study	PRICE SENSITIVE	07/06/22	1.06MB	Share
OCC	Orthocell Receives A$2.1m R&D Tax Incentive Refund	PRICE SENSITIVE	03/06/22	188.36KB	Share
OCC	Notification regarding unquoted securities - OCC		12/05/22	27.41KB	Share
OCC	Appendix 4C - Quarterly	PRICE SENSITIVE	29/04/22	672.37KB	Share
OCC	Notification regarding unquoted securities - OCC		21/04/22	28.25KB	Share
OCC	Regulatory Approval for Remplir Nerve Repair Device	PRICE SENSITIVE	21/03/22	295.27KB	Share
OCC	Trading Halt	PRICE SENSITIVE	17/03/22	354.77KB	Share
OCC	Pause in Trading	PRICE SENSITIVE	17/03/22	115.43KB	Share
OCC	Striate US Market Entry Update	PRICE SENSITIVE	28/02/22	185.75KB	Share
OCC	Half Yearly Report and Accounts	PRICE SENSITIVE	23/02/22	1.18MB	Share
OCC	Appendix 4C - Quarterly	PRICE SENSITIVE	31/01/22	728.61KB	Share
OCC	Notice under Section 708(A) of the Corporations Act		30/12/21	146.02KB	Share
OCC	Application for quotation of securities - OCC		30/12/21	24.88KB	Share
OCC	Notice under Section 708(A) of the Corporations Act		23/12/21	146.21KB	Share
OCC	Application for quotation of securities - OCC		23/12/21	24.89KB	Share
OCC	Change of Registry Address		20/12/21	152.9KB	Share
OCC	Notice under Section 708(A) of the Corporations Act		16/12/21	146.23KB	Share
OCC	Application for quotation of securities - OCC		16/12/21	24.88KB	Share
OCC	Successful SmrtGraft Shoulder Study Published	PRICE SENSITIVE	16/12/21	239.16KB	Share
OCC	OrthoATI Tendon Clinical Study Success	PRICE SENSITIVE	08/12/21	1.39MB	Share
OCC	Trading Halt	PRICE SENSITIVE	07/12/21	549.94KB	Share
OCC	Notice under Section 708(A) of the Corporations Act		18/11/21	146.2KB	Share
OCC	Application for quotation of securities - OCC		18/11/21	24.88KB	Share
OCC	Ortho-ATI Shoulder Tendon Study Database Lock	PRICE SENSITIVE	15/11/21	220.73KB	Share
OCC	Notice under Section 708(A) of the Corporations Act		09/11/21	146.19KB	Share
OCC	Application for quotation of securities - OCC		09/11/21	24.91KB	Share
OCC	Appendix 4C - Quarterly	PRICE SENSITIVE	29/10/21	684.82KB	Share
OCC	Presentation - Canaccord Genuity South-West Connect Showcase		28/10/21	4.65MB	Share
OCC	Results of Meeting		27/10/21	138.94KB	Share
OCC	Notification regarding unquoted securities - OCC		26/10/21	27.33KB	Share
OCC	Notification regarding unquoted securities - OCC		26/10/21	27.34KB	Share
OCC	Notification regarding unquoted securities - OCC		26/10/21	25.53KB	Share
OCC	Notification regarding unquoted securities - OCC		26/10/21	23.63KB	Share
OCC	Notification regarding unquoted securities - OCC		26/10/21	23.63KB	Share
OCC	Notice under Section 708(A) of the Corporations Act		18/10/21	146.96KB	Share
OCC	Application for quotation of securities - OCC		18/10/21	24.87KB	Share
OCC	Change of Director's Interest Notices		24/09/21	453.42KB	Share
OCC	Letter to Shareholders - Annual General Meeting		21/09/21	153.27KB	Share
OCC	Notice of Annual General Meeting/Proxy Form		21/09/21	771.03KB	Share
OCC	Notice under Section 708(A) of the Corporations Act		16/09/21	146.22KB	Share
OCC	Application for quotation of securities - OCC		16/09/21	24.84KB	Share
OCC	Proposed issue of securities - OCC		16/09/21	25.51KB	Share
OCC	Proposed issue of securities - OCC		16/09/21	24.2KB	Share
OCC	Positive Data for CelGro Collagen Rope in ACL Reconstruction	PRICE SENSITIVE	15/09/21	712.62KB	Share
OCC	OCC Secures Patents for Suture-Less Repair of Soft Tissue	PRICE SENSITIVE	07/09/21	278.59KB	Share
OCC	Proactive Investors Interview with Orthocells MD		02/09/21	129.51KB	Share
OCC	Ortho-ATI Shoulder Tendon Study Update Revised	PRICE SENSITIVE	31/08/21	236.6KB	Share
OCC	Ortho-ATI Shoulder Tendon Study Update	PRICE SENSITIVE	31/08/21	222.58KB	Share
OCC	Appendix 4E and Annual Report to Shareholders	PRICE SENSITIVE	27/08/21	4.28MB	Share
OCC	Appendix 4G		27/08/21	303.46KB	Share
OCC	Annual General Meeting		27/08/21	151.95KB	Share
OCC	CelGro Nerve Study Results Presented at AOA annual Meeting		23/08/21	243.95KB	Share
OCC	Notice under Section 708(A) of the Corporations Act		19/08/21	146.24KB	Share
OCC	Application for quotation of securities - OCC		19/08/21	24.84KB	Share
OCC	Notice under Section 708(A) of the Corporations Act		11/08/21	146.26KB	Share
OCC	Application for quotation of securities - OCC		11/08/21	24.84KB	Share
OCC	CelGro Facilitates Lymphatic Vessel Regeneration Updated	PRICE SENSITIVE	02/08/21	309.97KB	Share
OCC	CelGro Facilitates Lymphatic Vessel Regeneration	PRICE SENSITIVE	02/08/21	211.45KB	Share
OCC	Appendix 4C - Quarterly	PRICE SENSITIVE	28/07/21	728.61KB	Share
OCC	Orthocell Appoints Exclusive Distributor in Australia	PRICE SENSITIVE	13/07/21	244.78KB	Share
OCC	Notice under Section 708(A) of the Corporations Act		30/06/21	146.45KB	Share
OCC	Application for quotation of securities - OCC		30/06/21	24.81KB	Share
OCC	Application for quotation of securities - OCC		30/06/21	25.05KB	Share

OCC Orthocell Appoints Non-Executive Director Dr Ravi Thadhani
08/03/23		231.18KB	Share
OCC Orthocell appoints Company Secretary Mr Peter Webse
01/03/23		132.61KB	Share
OCC Half Yearly Report and Accounts
28/02/23	PRICE SENSITIVE	4.16MB	Share
OCC Investor Presentation
02/02/23		12.22MB	Share
OCC Appendix 4C - Quarterly
30/01/23	PRICE SENSITIVE	456.15KB	Share
OCC Change of Director's Interest Notice PA
23/11/22		196.01KB	Share
OCC Change of Director's Interest Notice LL
23/11/22		197.93KB	Share
OCC Notification of cessation of securities - OCC
23/11/22		22.56KB	Share
OCC Notification of cessation of securities - OCC
23/11/22		22.49KB	Share
OCC Change of Director's Interest Notice LL Revised
11/11/22		320.85KB	Share
OCC Change of Director's Interest Notice LL
09/11/22		198.1KB	Share
OCC Remplir Gains Australian Reimbursement
01/11/22	PRICE SENSITIVE	299.94KB	Share
OCC Appendix 4C - Quarterly
31/10/22	PRICE SENSITIVE	442.67KB	Share
OCC Results of Meeting
28/10/22		140.26KB	Share
OCC Investor Presentation
26/10/22		5.72MB	Share
OCC OrthoATI Rotator Cuff Study Success With Cross-Over Patients
29/09/22	PRICE SENSITIVE	273.87KB	Share
OCC Letter to Shareholders - Annual General Meeting
28/09/22		727.9KB	Share
OCC Notice of Annual General Meeting/Proxy Form
28/09/22		851.1KB	Share
OCC First orders for Striate and Remplir
27/09/22	PRICE SENSITIVE	185.26KB	Share
OCC Appointment of Exclusive Australian Distributor for Remplir
07/09/22	PRICE SENSITIVE	328.63KB	Share
OCC Trading Halt
06/09/22	PRICE SENSITIVE	564.01KB	Share
OCC Annual General Meeting
05/09/22		151.23KB	Share
OCC Appendix 4G
31/08/22		304.06KB	Share
OCC Final Report and Annual Report to Shareholders
31/08/22	PRICE SENSITIVE	5.09MB	Share
OCC Notice under Section 708(A) of the Corporations Act
17/08/22		146.15KB	Share
OCC Notification of cessation of securities - OCC
17/08/22		22.54KB	Share
OCC Application for quotation of securities - OCC
17/08/22		26.67KB	Share
OCC Appendix 4C - Quarterly
29/07/22	PRICE SENSITIVE	541.28KB	Share
OCC Updated Investor Presentation
27/07/22		6.08MB	Share
OCC Striate Global License and Distribution Agreement Update
21/07/22	PRICE SENSITIVE	211.95KB	Share
OCC Option Terms and Conditions
15/07/22		200.03KB	Share
OCC Notification regarding unquoted securities - OCC
14/07/22		28.25KB	Share
OCC Notification regarding unquoted securities - OCC
14/07/22		24.98KB	Share
OCC Notification of cessation of securities - OCC
29/06/22		22.48KB	Share
OCC OCC Signs Striate Global License And Manufacturing Agreement
27/06/22	PRICE SENSITIVE	205.1KB	Share
OCC Trading Halt
24/06/22	PRICE SENSITIVE	553.19KB	Share
OCC Notification of cessation of securities - OCC
15/06/22		22.48KB	Share
OCC Final Data Readout for Orthocells Nerve Reconstruction Study
07/06/22	PRICE SENSITIVE	1.06MB	Share
OCC Orthocell Receives A$2.1m R&D Tax Incentive Refund
03/06/22	PRICE SENSITIVE	188.36KB	Share
OCC Notification regarding unquoted securities - OCC
12/05/22		27.41KB	Share
OCC Appendix 4C - Quarterly
29/04/22	PRICE SENSITIVE	672.37KB	Share
OCC Notification regarding unquoted securities - OCC
21/04/22		28.25KB	Share
OCC Regulatory Approval for Remplir Nerve Repair Device
21/03/22	PRICE SENSITIVE	295.27KB	Share
OCC Trading Halt
17/03/22	PRICE SENSITIVE	354.77KB	Share
OCC Pause in Trading
17/03/22	PRICE SENSITIVE	115.43KB	Share
OCC Striate US Market Entry Update
28/02/22	PRICE SENSITIVE	185.75KB	Share
OCC Half Yearly Report and Accounts
23/02/22	PRICE SENSITIVE	1.18MB	Share
OCC Appendix 4C - Quarterly
31/01/22	PRICE SENSITIVE	728.61KB	Share
OCC Notice under Section 708(A) of the Corporations Act
30/12/21		146.02KB	Share
OCC Application for quotation of securities - OCC
30/12/21		24.88KB	Share
OCC Notice under Section 708(A) of the Corporations Act
23/12/21		146.21KB	Share
OCC Application for quotation of securities - OCC
23/12/21		24.89KB	Share
OCC Change of Registry Address
20/12/21		152.9KB	Share
OCC Notice under Section 708(A) of the Corporations Act
16/12/21		146.23KB	Share
OCC Application for quotation of securities - OCC
16/12/21		24.88KB	Share
OCC Successful SmrtGraft Shoulder Study Published
16/12/21	PRICE SENSITIVE	239.16KB	Share
OCC OrthoATI Tendon Clinical Study Success
08/12/21	PRICE SENSITIVE	1.39MB	Share
OCC Trading Halt
07/12/21	PRICE SENSITIVE	549.94KB	Share
OCC Notice under Section 708(A) of the Corporations Act
18/11/21		146.2KB	Share
OCC Application for quotation of securities - OCC
18/11/21		24.88KB	Share
OCC Ortho-ATI Shoulder Tendon Study Database Lock
15/11/21	PRICE SENSITIVE	220.73KB	Share
OCC Notice under Section 708(A) of the Corporations Act
09/11/21		146.19KB	Share
OCC Application for quotation of securities - OCC
09/11/21		24.91KB	Share
OCC Appendix 4C - Quarterly
29/10/21	PRICE SENSITIVE	684.82KB	Share
OCC Presentation - Canaccord Genuity South-West Connect Showcase
28/10/21		4.65MB	Share
OCC Results of Meeting
27/10/21		138.94KB	Share
OCC Notification regarding unquoted securities - OCC
26/10/21		27.33KB	Share
OCC Notification regarding unquoted securities - OCC
26/10/21		27.34KB	Share
OCC Notification regarding unquoted securities - OCC
26/10/21		25.53KB	Share
OCC Notification regarding unquoted securities - OCC
26/10/21		23.63KB	Share
OCC Notification regarding unquoted securities - OCC
26/10/21		23.63KB	Share
OCC Notice under Section 708(A) of the Corporations Act
18/10/21		146.96KB	Share
OCC Application for quotation of securities - OCC
18/10/21		24.87KB	Share
OCC Change of Director's Interest Notices
24/09/21		453.42KB	Share
OCC Letter to Shareholders - Annual General Meeting
21/09/21		153.27KB	Share
OCC Notice of Annual General Meeting/Proxy Form
21/09/21		771.03KB	Share
OCC Notice under Section 708(A) of the Corporations Act
16/09/21		146.22KB	Share
OCC Application for quotation of securities - OCC
16/09/21		24.84KB	Share
OCC Proposed issue of securities - OCC
16/09/21		25.51KB	Share
OCC Proposed issue of securities - OCC
16/09/21		24.2KB	Share
OCC Positive Data for CelGro Collagen Rope in ACL Reconstruction
15/09/21	PRICE SENSITIVE	712.62KB	Share
OCC OCC Secures Patents for Suture-Less Repair of Soft Tissue
07/09/21	PRICE SENSITIVE	278.59KB	Share
OCC Proactive Investors Interview with Orthocells MD
02/09/21		129.51KB	Share
OCC Ortho-ATI Shoulder Tendon Study Update Revised
31/08/21	PRICE SENSITIVE	236.6KB	Share
OCC Ortho-ATI Shoulder Tendon Study Update
31/08/21	PRICE SENSITIVE	222.58KB	Share
OCC Appendix 4E and Annual Report to Shareholders
27/08/21	PRICE SENSITIVE	4.28MB	Share
OCC Appendix 4G
27/08/21		303.46KB	Share
OCC Annual General Meeting
27/08/21		151.95KB	Share
OCC CelGro Nerve Study Results Presented at AOA annual Meeting
23/08/21		243.95KB	Share
OCC Notice under Section 708(A) of the Corporations Act
19/08/21		146.24KB	Share
OCC Application for quotation of securities - OCC
19/08/21		24.84KB	Share
OCC Notice under Section 708(A) of the Corporations Act
11/08/21		146.26KB	Share
OCC Application for quotation of securities - OCC
11/08/21		24.84KB	Share
OCC CelGro Facilitates Lymphatic Vessel Regeneration Updated
02/08/21	PRICE SENSITIVE	309.97KB	Share
OCC CelGro Facilitates Lymphatic Vessel Regeneration
02/08/21	PRICE SENSITIVE	211.45KB	Share
OCC Appendix 4C - Quarterly
28/07/21	PRICE SENSITIVE	728.61KB	Share
OCC Orthocell Appoints Exclusive Distributor in Australia
13/07/21	PRICE SENSITIVE	244.78KB	Share
OCC Notice under Section 708(A) of the Corporations Act
30/06/21		146.45KB	Share
OCC Application for quotation of securities - OCC
30/06/21		24.81KB	Share
OCC Application for quotation of securities - OCC
30/06/21		25.05KB	Share

REFRESH

First 2 3 4 5 6

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $1.24		Change 0.005(0.41%)		Mkt cap ! $307.2M

Open	High	Low	Value	Volume
$1.24	$1.27	$1.24	$769.6K	616.1K

Buyers (Bids)

No.	Vol.	Price($)
5	65284	$1.23

Sellers (Offers)

Price($)	Vol.	No.
$1.24	5606	3

View Market Depth

No.	Vol.	Price($)
5	65284	1.230
4	31469	1.225
3	16136	1.220
2	5553	1.215
2	40745	1.210

Price($)	Vol.	No.
1.240	5606	3
1.245	20632	6
1.250	12847	6
1.255	2068	3
1.260	3430	2

Last trade - 12.09pm 13/08/2025 (20 minute delay)


Last $1.24		Change 0.005 ( 1.41 %)
Open	High	Low	Volume
$1.25	$1.27	$1.23	104292
Last updated 12.24pm 13/08/2025 ?

OCC (ASX) Chart

ORTHOCELL LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories